N	Concordance
1	reated with either a progestin, such as megestrol acetate or medroxyprogesterone
2	cute-phase response (n = 15) were given megestrol acetate (480 mg day(-1)) and i
3	ies which have looked at the effects of Megestrol acetate on women with breast c
4	mly assigned to a dose-finding study of megestrol. The first patient cohort rec
5	l agents such as medroxyprogesterone or megestrol acetate are used in the treatm
6	apy are treated with oral  tamoxifen or megestrol. Patients may receive radioth
7	 the clinical effects of high-dose oral megestrol in improving regression rate 
8	nd that their periods stop while taking Megestrol acetate it is not a contracept
9	fficiency were identified. Therapy with megestrol can result in clinical manifes
10	te of disease, and prior treatment with megestrol. Breast cancer patients are r